Two Top Stocks to Discuss: Spotify Technology S.A. (NYSE:SPOT), Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Spotify Technology S.A. (NYSE:SPOT)

Spotify Technology S.A. (NYSE:SPOT) closed at $141.57 on the last trading session with an decrease of -1.89%, whereas, it previously closed at $144.3. The company has a market capitalization of $26.11 Billion. The company traded shares of 1.21 Million on the trading day while its three month average volume stands at 1.29 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Spotify Technology S.A. (NYSE:SPOT) produced diluted EPS of 2.8. The EPS estimate for next year as estimated by analysts is at -0.14 while EPS for next quarter is estimated at -0.23. Earnings per Share growth for this year is reported at 94.6, while the analysts estimated the EPS growth for next year at -0.14% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 2.8%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Spotify Technology S.A. (NYSE:SPOT) is at 50.56 while the forward p/e is at 0. The P/S or Price to Sales ratio of Spotify Technology S.A. (NYSE:SPOT) stands at 3.66 and Price to Book or P/B for the most recent quarter stands at 11.76. The Price to Free Cash Flow ratio or P/FCF is reported at 66.55. The quick ratio and the current ratio of Spotify Technology S.A. (NYSE:SPOT) are reported at 0.8 and 0.8 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Spotify Technology S.A. (NYSE:SPOT) stands at 9.3, 22 and 2.4 respectively

The trailing twelve month Revenue of Spotify Technology S.A. (NYSE:SPOT) is reported at 7.14 Billion with income of 518.4 Million. The outstanding shares of Spotify Technology S.A. (NYSE:SPOT) are 184.46 Million. The institutional Ownership of the shares of 55.3 stands at 0.80%, this figure is increased 0.09 in the last six months. The insider ownership for the shares of Spotify Technology S.A. (NYSE:SPOT) is ticked at 43.54%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Spotify Technology S.A. (NYSE:SPOT) is the Mean Target Price estimated by the analysts which stands at 165.19. The 52 week high of Spotify Technology S.A. (NYSE:SPOT) is placed at 161.38 and 52 week low is standing at 110.57.

Performance wise the shares of Spotify Technology S.A. (NYSE:SPOT) fell down -4.42% for the week, it also fell -7.57% for the monthly performance, while for the quarter it went down 0.98%. The shares decrease -8.78% for the half year and plummeted for the Year-To-Date performance. The shares of Spotify Technology S.A. (NYSE:SPOT) grew 6.88% for the yearly performance.

Intellia Therapeutics, Inc. (NASDAQ:NTLA)

Intellia Therapeutics, Inc. (NASDAQ:NTLA) closed at $13.07 on the last trading session with an decrease of -2.83%, whereas, it previously closed at $13.45. The company has a market capitalization of $625.01 Million. The company traded shares of 510255 on the trading day while its three month average volume stands at 663.63 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) produced diluted EPS of -1.96. The EPS estimate for next year as estimated by analysts is at -2.43 while EPS for next quarter is estimated at -0.56. Earnings per Share growth for this year is reported at -5.6, while the analysts estimated the EPS growth for next year at -2.43% and Earnings growth for next 5 years stands at 30% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 0%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Intellia Therapeutics, Inc. (NASDAQ:NTLA) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Intellia Therapeutics, Inc. (NASDAQ:NTLA) stands at 15.63 and Price to Book or P/B for the most recent quarter stands at 2.3. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Intellia Therapeutics, Inc. (NASDAQ:NTLA) are reported at 7.9 and 7.9 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Intellia Therapeutics, Inc. (NASDAQ:NTLA) stands at -26, -33 and 0 respectively

The trailing twelve month Revenue of Intellia Therapeutics, Inc. (NASDAQ:NTLA) is reported at 40 Million with income of -90300000. The outstanding shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) are 47.82 Million. The institutional Ownership of the shares of 76.9 stands at 0.80%, this figure is decreased -0.2 in the last six months. The insider ownership for the shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) is ticked at 19.98%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Intellia Therapeutics, Inc. (NASDAQ:NTLA) is the Mean Target Price estimated by the analysts which stands at 28.65. The 52 week high of Intellia Therapeutics, Inc. (NASDAQ:NTLA) is placed at 19.00 and 52 week low is standing at 10.26.

Performance wise the shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) fell down -10.72% for the week, it also fell -15.02% for the monthly performance, while for the quarter it went down 10.76%. The shares decrease -29.39% for the half year and plummeted for the Year-To-Date performance. The shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA) grew 0.62% for the yearly performance.